Search filters

List of works by Jeremy S Abramson

A virtual resiliency program for lymphoma survivors: helping survivors cope with post-treatment challenges

scientific article published on 28 November 2020

Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnership.

scientific article published on July 2014

Bone marrow biopsies for staging of diffuse large B-cell lymphoma: are we looking too closely?

scientific article published on 25 October 2016

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma

scientific article published on 11 June 2019

Case records of the Massachusetts General Hospital. Case 24-2010. A 56-year-old woman with a history of Hodgkin's lymphoma and sudden onset of dyspnea and shock

scientific article published on 01 August 2010

Case records of the Massachusetts General Hospital. Case 27-2009. A 56-year-old woman with fever, rash, and lymphadenopathy.

scientific article published on August 2009

Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia

scientific article published on 01 December 2008

Case records of the Massachusetts General Hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation

scientific article

Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions.

scientific article published on 20 May 2016

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

scientific article published on March 2015

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

scientific article published on 11 December 2017

Diffuse Large B-Cell Lymphoma Version 1.2016

scientific article published on 01 February 2016

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

scientific article published on 01 December 2018

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia

scientific article published on 01 April 2019

Evaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21

scientific article published on 18 July 2020

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

scientific article published on 07 January 2019

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

scientific article published on 4 June 2015

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.

scientific article published on 5 January 2012

Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

scientific article published in November 2017

Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?

scientific article published on 09 July 2019

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

scientific article published on 26 August 2014

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma

scientific article

Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain

scientific article published on April 3, 2011

MYC/BCL2 double-expression vs. cell-of-origin classification in diffuse large B-cell lymphoma: do we need to know both?

scientific article published on 23 December 2015

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

scientific article published on 26 May 2020

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

scientific article

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

scientific article

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

scientific article

Non-Hodgkin's Lymphomas, version 3.2012

scientific article published on 01 December 2012

Non-Hodgkin's lymphomas

scientific article published on 01 May 2011

Non-Hodgkin's lymphomas, version 1.2013.

scientific article

Non-Hodgkin's lymphomas, version 2.2014

scientific article published on 01 June 2014

Non-Hodgkin's lymphomas, version 4.2014.

scientific article published on September 2014

Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study

scientific article

Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study

scientific article published on 28 June 2018

Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas

scientific article published on 01 July 2020

Primary subcutaneousAlternaria alternatainfection of the hand in an immunocompromised host

scientific article published on 07 February 2011

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud

scientific article published on 23 September 2014

Recent advances in the treatment of non-Hodgkin's lymphomas.

scientific article published on May 2013

Recurrent mutations and targeted therapy in FL

scientific article published on 01 January 2017

Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma

scientific article published on 10 September 2019

T-cell/histiocyte-rich B-cell lymphoma and the paradox of the host immune response

scientific article published on 01 September 2007

The Spectrum of Double Hit Lymphomas

scientific article published on December 2016

The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.

scientific article

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

scientific article published on 18 July 2019

Unanswered Questions in HIV Hematology

scientific article published on 4 June 2012